-
Consumer Insights
NewMass Affluent Banking in Greater China – Regional Breakdown by Market Trends, Investment Preferences and Competitor Benchmarking
Mass Affluent Banking Market in Greater China Report Overview Emerging affluents and mass affluents make up most of the affluent population in the Greater China region. The population of affluents has been exponential in the last decade in the region. However, the growth is expected to slow down in the upcoming years as the economies mature. Despite low growth, the number of mass affluent customers in the region is exceedingly large, offering a huge market to the financial providers looking...
-
Analyst Opinions
NewDevelopment of Electric Mining Vehicles in Surface and Underground Mining, 2024
As miners strive to reduce greenhouse gas emissions, many are beginning to invest in battery-powered and electric-powered mining fleets as they embark on the long-term goal of diesel displacement. 'The pace of switching to electric mining vehicles is increasing. Underground over 320 LHDs and mining trucks were running on electric power by March 2024, while for surface mines the use of electric-powered mining trucks has been picking up with almost 240 trolley-assist trucks and 129 battery-powered surface trucks.
-
Sector Analysis
NewESG State of Play and Telco Approaches
ESG State of Play and Telco Approaches Report Overview Major tech and telecom companies have a stated commitment to ESG, but their goals, delivery, and reporting can vary substantially. TMT companies are among the key players in the race to net zero. They are not only reducing their carbon footprint, but also enabling others to decarbonize by offering solutions for resource optimization, productivity enhancement, and innovation support. Many telecom operators are publishing sustainability reports which have substantial detail on areas...
-
Product Insights
NewLikelihood of Approval Analysis for Non-infectious Uveitis
Overview How likely is it that the drugs in Non-infectious Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-infectious Uveitis Overview Non-infectious uveitis (NIU) is a group of disorders characterized...
-
Macroeconomic Analysis
NewGlobal Risk Report Quarterly Update – Q1 2024
Global Risk Report Overview In Q1 2024, global geopolitical risks are at a tipping point with key hotspots threatening international stability. Conflicts in the Middle East, which contribute to shipping disruptions and inflationary pressures threaten global trade. Meanwhile, recent developments on the Korean peninsula, including Pyongyang's shift in reunification goals have raised concerns about rising tensions. These dynamics highlight the critical need for strategic diplomacy and risk management efforts to navigate today's global landscape. the potential dangers of uncontrollable self-aware...
-
Product Insights
NewLikelihood of Approval Analysis for Relapsed Chronic Lymphocytic Leukemia (CLL)
Overview How likely is it that the drugs in Relapsed Chronic Lymphocytic Leukemia (CLL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Relapsed Chronic Lymphocytic Leukemia (CLL) Overview Relapsed Chronic Lymphocytic...
-
Product Insights
NewLikelihood of Approval Analysis for Human Immunodeficiency Virus (HIV) Infections (AIDS)
Overview How likely is it that the drugs in Human Immunodeficiency Virus (HIV) Infections (AIDS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Immunodeficiency Virus (HIV) Infections (AIDS) Overview Human...
-
Product Insights
NewLikelihood of Approval Analysis for Retinal Vascular Occlusion
Overview How likely is it that the drugs in Retinal Vascular Occlusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Vascular Occlusion Overview Retinal vascular occlusion is a condition that...
-
Product Insights
NewLikelihood of Approval Analysis for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that the drugs in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-Cell Acute Lymphocytic Leukemia (B-Cell Acute...
-
Product Insights
NewLikelihood of Approval Analysis for Lennox-Gastaut Syndrome
Overview How likely is it that the drugs in Lennox-Gastaut Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lennox-Gastaut Syndrome Overview Lennox-Gastaut syndrome (LGS) is a severe form of epilepsy...